Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Blue Jet Healthcare's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹2,574 Mil.
Blue Jet Healthcare's average Total Assets over the quarter that ended in Mar. 2026 was ₹16,412 Mil. Therefore, Blue Jet Healthcare's annualized ROA % for the quarter that ended in Mar. 2026 was 15.68%.
The historical rank and industry rank for Blue Jet Healthcare's ROA % or its related term are showing as below:
BOM:544009'
s ROA % Range Over the Past 10 Years
Min: 16.2 Med: 22.49 Max: 29.06
Current: 16.21
During the past 6 years, Blue Jet Healthcare's highest ROA % was 29.06%. The lowest was 16.20%. And the median was 22.49%.
BOM:544009's ROA % is ranked better than 94.77% of 1416
companies
in the Biotechnology industry
Industry Median: -32.985
vs BOM:544009: 16.21
Blue Jet Healthcare (BOM:544009) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Blue Jet Healthcare ROA % Related Terms
Blue Jet Healthcare ROA % Historical Data
* Premium members only.
The historical data trend for Blue Jet Healthcare's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Blue Jet Healthcare's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Blue Jet Healthcare ROA % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Blue Jet Healthcare's ROA % distribution charts can be found below:
* The bar in red indicates where Blue Jet Healthcare's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Blue Jet Healthcare (BOM:544009) has a ROA % of 15.68% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Blue Jet Healthcare and its competitors. This is 30% below median its historical median of 22.49. Over the past decade, Blue Jet Healthcare's ROA % has ranged from 16.20 to 29.06. According to the industry distribution chart, Blue Jet Healthcare ranks #74 out of 1416 companies in the Biotechnology industry, placing it in the top 5.2%.
Is Blue Jet Healthcare's ROA % too high?
Blue Jet Healthcare's current ROA % of 15.68% is 30% below median its 10-year median of 22.49. Over the past 10 years, this metric has ranged from a low of 16.20 to a high of 29.06. Based on the distribution chart, Blue Jet Healthcare ranks #74 out of 1416 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Blue Jet Healthcare has a GF Score™ of 64/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Blue Jet Healthcare's ROA % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Blue Jet Healthcare ranks #74 out of 1416 companies for ROA %. This places Blue Jet Healthcare in the top 5% of its industry — outperforming the majority of peers. Historically, Blue Jet Healthcare's own ROA % has ranged from 16.20 to 29.06 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Biotechnology company?
A good ROA % depends on the Biotechnology industry context. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Blue Jet Healthcare and its competitors. Blue Jet Healthcare's current ROA % is 15.68%, which is 30% below median its own 10-year median of 22.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blue Jet Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Blue Jet Healthcare (BOM:544009) is currently considered Fairly Valued. The stock's GF Value™ is ₹562.05, compared to a current price of ₹584.70 — trading 4% above its estimated fair value. The current ROA % is 15.68%, which is 30% below median its 10-year median of 22.49. Blue Jet Healthcare's overall GF Score™ is 64/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Blue Jet Healthcare (BOM:544009), the current ROA % is 15.68% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Blue Jet Healthcare (BOM:544009) Overvalued in 2026?
Based on GuruFocus' analysis, Blue Jet Healthcare stock appears to be overvalued.
The current stock price of ₹584.70 is trading 4% above its estimated GF Value™ of ₹562.05.
GuruFocus considers Blue Jet Healthcare to be Fairly Valued.
Key valuation signals for BOM:544009:
ROA %: 15.68% (30% below median its 10-year median of 22.49)
GF Value™: ₹562.05 vs. price of ₹584.70 (4% above fair value)
No single metric tells the full story. See the BOM:544009 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Blue Jet Healthcare Ltd is engaged in manufacturing of Pharma Intermediate, APIs used in Pharmaceutical and Healthcare Products. The operations of the company are organized in three product categories which are contrast media intermediates, artificial sweeteners, pharma intermediates, and active pharmaceutical ingredients. Geographically, it operates in Norway, France, India and Rest of the World.
64GF Score
Get the complete analysis for BOM:544009
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544009 has been successfully added to your 
